1 Risk factors The development and progression of DN are influenced by various factors, including the duration of diabetes, glycemic control, age, obesity, dyslipidemia, insulin resistance, chronic low-grade inflammation, lifestyle choices, cardiovascular health, and genetic predispositions
(Cochrane Metabolic and Endocrine Disorders Group) (December 2018)
Some of these medications have demonstrated significant benefits in cardiovascular risk reduction in people with type 2 diabetes, with specific agents (including liraglutide, semaglutide and dulaglutide) showing reductions in major adverse cardiovascular events
You can use it in the morning (make sure you wear sunscreen after) and it generally works for all skin types
The active ingredient is semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist used to improve blood sugar control in adults with type 2 diabetes